High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors
European Patent
20804404.0
Filed on 2020-10-21
20804404.0
Filed on 2020-10-21
High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors
China
202080074414.2
Filed on 2020-10-21
202080074414.2
Filed on 2020-10-21
High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors
Canada
3156761
Filed on 2020-10-21
3156761
Filed on 2020-10-21
High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors
Australia
2020370125
Filed on 2020-10-21
2020370125
Filed on 2020-10-21
VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS
European Patent
22157548.3
Filed on 2022-02-18
22157548.3
Filed on 2022-02-18
T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53
Patent Cooperation Treaty
PCT/US2022/028066
Filed on 2022-05-06
PCT/US2022/028066
Filed on 2022-05-06
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION
Patent Cooperation Treaty
PCT/US2022/025177
Filed on 2022-04-18
PCT/US2022/025177
Filed on 2022-04-18
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT
United Kingdom
17805342.7
Filed on 2019-05-06
17805342.7
Filed on 2019-05-06
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT
Germany
17805342.7
Filed on 2019-05-06
17805342.7
Filed on 2019-05-06
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT
France
17805342.7
Filed on 2019-05-06
17805342.7
Filed on 2019-05-06